Diabetes & Endocrinology
High Hopes for DNA Packages that Correct Rare Disease Genes
AAV vector gene therapy, now in phase 1/2 trials, targets methylmalonic acidemia.
Glucagon-blocking Antibodies Restore β-cells in Diabetes Model
Glucagon antagonist promotes β-cell survival, supports new direction in basic research.
Targeting Collagen IV in GBM Diseases
Research highlights role of collagen IV in GBM dysfunction and potential therapeutic strategies.
“Pancreatlas” Offers Deep Dive into the Human Pancreas
First-of-its-kind imaging database is practical, comprehensive and open source.
Resurrecting Subcutaneous Insulin Aspart for Diabetic Ketoacidosis
Physicians are implementing an old gold standard to free up ICU beds during the pandemic.
Breakthrough Therapy for a Rare Metabolic Bone Disease
Burosumab may enable near-normal lives for children with XLH.
Inconsistent Sleep a Barrier to Glycemic Control in T1D
Experts test intervention to improve sleep habits in pediatric patients with T1D.
Vanderbilt Diabetes Researchers to Present at ENDO 2021
Join our experts as they share their latest discoveries in endocrinology research, plus clinical studies and translational initiatives.
RADIANT Sheds Light on Rare Types of Diabetes
Nationwide network to expand understanding beyond T1D and T2D.
